TrialGastroenterology2021

TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study.

Ciarán P Kelly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.